A systematic review and meta-analysis of gut microbiota in diabetic kidney disease: Comparisons with diabetes mellitus, non-diabetic kidney disease, and healthy individuals

被引:12
|
作者
Han, Shisheng [1 ]
Chen, Min [1 ]
Cheng, Pei [2 ]
Zhang, Zeng [3 ]
Lu, Yan [1 ]
Xu, Yanqiu [1 ]
Wang, Yi [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western M, Dept Nephrol, Shanghai, Peoples R China
[2] Linan Third Peoples Hosp, Dept Hemodialysis, Hangzhou, Zhejiang, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western M, Dept Endocrine, Shanghai, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
gut microbiota; diabetic kidney disease; diabetes mellitus; systematic review; meta-analysis; NEPHROPATHY; DIAGNOSIS;
D O I
10.3389/fendo.2022.1018093
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Gut microbiota has been reported to play an important role in diabetic kidney disease (DKD), however, the alterations of gut bacteria have not been determined. Methods: Studies comparing the differences of gut microbiome between patients with DKD and non-DKD individuals using high-throughput sequencing technology, were systematically searched and reviewed. Outcomes were set as gut bacterial diversity, microbial composition, and correlation with clinical parameters of DKD. Qualitative data were summarized and compared through a funnel R script, and quantitative data were estimated by meta-analysis. Results: A total of 15 studies and 1640 participants were included, the comparisons were conducted between DKD, diabetes mellitus (DM), non-diabetic kidney disease (NDKD), and healthy controls. There were no significant differences of alpha-diversity between DKD and DM, and between DKD and NDKD, however, significant lower microbial richness was found in DKD compared to healthy controls. Different bacterial compositions were found between DKD and non-DKD subjects. The phylum Actinobacteria were found to be enriched in DKD compared to healthy controls. At the genus level, we found the enrichment of Hungatella, Bilophila, and Escherichia in DKD compared to DM, patients with DKD showed lower abundances of Faecalibacterium compared to those with NDKD. The genera Butyricicoccus, Faecalibacterium, and Lachnospira were depleted in DKD compared to healthy controls, whereas Hungatella, Escherichia, and lactobacillus were significantly enriched. The genus Ruminococcus torques group was demonstrated to be inversely correlated with estimated glomerular filtration rate of DKD. Conclusions: Gut bacterial alterations was demonstrated in DKD, characterized by the enrichment of the genera Hungatella and Escherichia, and the depletion of butyrate-producing bacteria, which might be associated with the occurrence and development of DKD. Further studies are still needed to validate these findings, due to substantial heterogeneity.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Accuracy of hematuria for predicting non-diabetic renal disease in patients with diabetes and kidney disease: A systematic review and meta-analysis
    Jiang, Shimin
    Wang, Yining
    Zhang, Zheng
    Dai, Peilin
    Yang, Yue
    Li, Wenge
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 143 : 288 - 300
  • [2] Diabetic Retinopathy Is a Predictor of Progression of Diabetic Kidney Disease: A Systematic Review and Meta-Analysis
    Gupta, Mansi
    Rao, Indu Ramachandra
    Nagaraju, Shankar Prasad
    Bhandary, Sulatha, V
    Gupta, Jayanti
    Babu, Ganesh T. C.
    [J]. INTERNATIONAL JOURNAL OF NEPHROLOGY, 2022, 2022
  • [3] VALIDATION OF A DIFFERENTIAL DIAGNOSTIC MODEL OF DIABETIC KIDNEY DISEASE AND NON-DIABETIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Tan, Hui Zhuan
    Kwek, Jia Liang
    Fook-Chong, Stephanie
    Chan, Choong Meng
    Choo, Jason Chon Jun
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [4] Fufang Xueshuantong for Diabetic Kidney Disease: A Systematic Review and Meta-Analysis
    Tan, Yu-meng
    Hu, Jun
    Wu, Qian
    Zhang, Yi
    Suo, Wen-dong
    Zhou, Yu-tong
    Guo, He
    Ni, Qing
    [J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [5] The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases-A Systematic Review and Meta-Analysis
    Wang, Yuwei
    Zhao, Jin
    Qin, Yunlong
    Yu, Zixian
    Zhang, Yumeng
    Ning, Xiaoxuan
    Sun, Shiren
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Diabetic kidney disease: the kidney disease relevant to individuals with diabetes
    Kanasaki, Keizo
    Ueki, Kohjiro
    Nangaku, Masaomi
    [J]. CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2024,
  • [7] Urinary metabolomics: to distinguish diabetic kidney disease from non-diabetic kidney disease
    Ghosh, S.
    Manna, S. K.
    Basu, M.
    Pulai, S.
    Banerjee, M.
    Raychoudhury, A.
    Bhattacharyya, N.
    [J]. DIABETOLOGIA, 2019, 62 : S456 - S456
  • [8] Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus
    He, Xin
    Sun, Jiping
    Liu, Chao
    Yu, Xiaoyang
    Li, Huixian
    Zhang, Wenjing
    Li, Yan
    Geng, Yingzhou
    Wang, Zhigang
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 755 - 765
  • [9] The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease: a systematic review and meta-analysis
    Congyuan Ma
    Xuanwei Li
    Wenlai Li
    Yue Li
    Fangfang Shui
    Ping Zhu
    [J]. International Urology and Nephrology, 2023, 55 : 3167 - 3174
  • [10] The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease: a systematic review and meta-analysis
    Ma, Congyuan
    Li, Xuanwei
    Li, Wenlai
    Li, Yue
    Shui, Fangfang
    Zhu, Ping
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (12) : 3167 - 3174